Super Current Affairs

Science & Tech

CCMB identifies NR2F1 and NR2F6 genes that promote spinal nerve regeneration in mice

20 November 20263 min1 source4 questionsStory 38 of 62

Source:The HinduThe Hindu

Subject: Science and Technology: Biotechnology, Health and Disease

Key points for Prelims: NR2F1 and NR2F6 genes, CSIR-Centre for Cellular and Molecular Biology (CCMB), Spinal cord injury and nerve regeneration, Gene-based therapy, The EMBO Journal

Mains syllabus mapping

  • General Studies Paper 3: Science and technology: developments and applications in biotechnology, health and everyday life; indigenous research and innovation
  • General Studies Paper 2: Health: issues relating to health, and the role of research institutions in healthcare

Key facts for one-day exams

  • NR2F1 and NR2F6 promoted nerve-fibre regeneration in mice.
  • The research was conducted at CSIR-CCMB in Hyderabad.
  • Ishwariya Venkatesh led the study.
  • The activity of NR2F1 and NR2F6 declines by 70-80% in adult brains.
  • The findings appeared in The EMBO Journal.

CCMB nerve regeneration genes: why in the news?

A CCMB-led study published in The EMBO Journal has identified two genes, NR2F1 and NR2F6, that can promote nerve-fibre regrowth after complete spinal cord injury in mice, offering a potential framework for future gene-based therapies for paralysis.

Scientists at the CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad, have identified two genes, NR2F1 and NR2F6, that can restore the ability of damaged nerve cells to regenerate, raising the possibility of new gene-based treatments for paralysis caused by spinal cord injuries. The study, led by Ishwariya Venkatesh and published in The EMBO Journal, found that activating either gene enabled severed nerve fibres to regrow across completely injured spinal cords in mice, leading to measurable improvements in movement.

The researchers investigated why young neurons can grow and regenerate while adult neurons cannot. They discovered that the activity of NR2F1 and NR2F6 declines by 70-80% in adult brains. Restoring either gene in adult mice prompted damaged nerve fibres to regenerate across the injury site and extend beyond it, while untreated animals showed little or no regrowth. Treated mice also showed improved mobility, including better hind-limb movement and grip strength, with recovery becoming evident about five weeks after the injury and continuing thereafter.

The two genes triggered regeneration through different mechanisms. NR2F1 activated genes involved in remodelling DNA and rebuilding cellular structures needed for growth, while NR2F6 suppressed several routine cellular activities, allowing neurons to redirect resources towards repairing damaged nerve fibres. The team also found that NR2F6 reorganises the three-dimensional structure of DNA in injured neurons, bringing growth-related genes closer to the regulatory elements that control their activity. Researchers said this was the first evidence linking large-scale genome reorganisation to nerve regeneration in the brain or spinal cord. The study is still at the preclinical stage; the genes were delivered before the injury in mice, and the recovery was partial.

What is the CSIR-Centre for Cellular and Molecular Biology?

The CSIR-Centre for Cellular and Molecular Biology (CCMB) is a premier life sciences research institute under the Council of Scientific and Industrial Research (CSIR), located in Hyderabad. It was established in 1977, initially as a semi-autonomous unit, with Dr. P. M. Bhargava as its founder director. The institute focuses on fundamental research in modern biology, including areas like genetics, cell biology, and molecular medicine. It operates under the administrative umbrella of CSIR, which was itself founded in 1942 as India's largest research and development organisation.

Why do adult nerve cells fail to regenerate?

The spinal cord carries signals between the brain and the rest of the body, enabling movement and sensation. In adult mammals, nerve cells generally lose their ability to regenerate after injury, so spinal cord damage can cause paralysis. The CCMB team investigated the difference between the growth capacity of young and adult neurons, focusing on proteins that activate growth-related genes during development but become less active as the brain matures.

How did the two genes work differently?

NR2F1 activated genes involved in DNA remodelling and rebuilding cellular structures required for growth. NR2F6, on the other hand, suppressed several routine cellular activities, allowing neurons to redirect resources toward repair. It also reorganised the three-dimensional structure of DNA, bringing growth-related genes closer to the regulatory elements that control their activity. Researchers said this was the first evidence linking large-scale genome reorganisation to nerve regeneration in the brain or spinal cord.

What are the study's limitations and next steps?

The study is still at the preclinical stage. The genes were delivered before the injury in mice, and the recovery was partial. Whether comparable benefits can be achieved after injury or in humans remains to be established. The findings, however, offer a potential framework for developing gene-based therapies to repair spinal cord damage.

NR2F1 and NR2F6 mechanisms

GeneObserved mechanism
NR2F1Activates DNA remodelling and growth-related genes
NR2F6Suppresses routine activities and reorganises DNA

Key terms

Spinal cord:
The spinal cord is part of the central nervous system and carries signals between the brain and the body.
Neuron:
A neuron is a specialised nerve cell that receives and transmits information through electrical and chemical signals.
Gene regulation:
Gene regulation is the control of when, where and how much a gene is expressed.
Preclinical study:
A preclinical study investigates a potential treatment before testing it in human clinical trials.

CCMB nerve regeneration genes: why it matters for exams

Syllabus: Science and Technology: Biotechnology and gene regulation; Science and Technology: Human nervous system

Common mistake: Examiners may present the mouse study as a proven human treatment: the research is preclinical, with genes delivered before injury and only partial recovery.

Mains practice questions

Question 1(GS-3 | 250 words | 15 marks)

Critically examine the potential of gene-based therapies, such as the NR2F1 and NR2F6 findings in mice, to treat paralysis caused by spinal cord injuries, and discuss the challenges that must be overcome before such therapies reach patients.

Answer outline

  • Introduction: Open by noting that CCMB Hyderabad's study shows two genes can restart nerve regrowth in mice with complete spinal cord injury, offering hope but still at the preclinical stage.
  • Body:
    • Explain the promise: the genes reverse the age-related decline in regenerative activity, and treated mice regained partial hind-limb movement and grip strength.
    • Mechanisms: NR2F1 activates genes for DNA remodelling and cell structure, while NR2F6 suppresses routine activities and reorganises DNA so that growth-related genes are reached.
    • Limitations: genes were delivered before injury in mice, recovery was partial, and results need validation in larger animals and humans.
    • Translational hurdles: safe delivery of gene therapy to the spinal cord, long-term effects of altering gene activity, ethical and regulatory oversight, and cost and access in India.
    • Indian research ecosystem: the role of CSIR labs and the need for clinical trial infrastructure and biotech regulation.
  • Conclusion: Gene therapy for paralysis is a promising but early frontier; sustained preclinical work, rigorous safety testing and a strong regulatory framework must precede any clinical use.

Question 2(GS-3 | 150 words | 10 marks)

Discuss how the discovery that adult neurons lose regenerative capacity, with NR2F1 and NR2F6 activity falling by 70-80%, can inform the development of therapies for neurological disorders, and evaluate the role of Indian research institutions in advancing such biomedical science.

Answer outline

  • Introduction: Introduce the finding that young neurons regenerate while adult neurons do not, and that the decline in NR2F1 and NR2F6 activity in adults is a key reason.
  • Body:
    • Scientific insight: ageing-linked loss of regulatory gene activity is a possible target for restoring repair capacity in the brain and spinal cord.
    • Therapeutic scope: the same principle may guide approaches to other neurological conditions where nerve fibres are damaged.
    • Role of CCMB: a CSIR laboratory publishing in The EMBO Journal shows domestic capacity in frontier molecular biology.
    • Gaps to address: funding, translational research pipelines and linking basic discoveries to clinical trials.
  • Conclusion: Understanding why adult neurons stop regenerating opens a path to new therapies, and sustained investment in institutions like CCMB can convert such basic findings into benefits for patients.

Stuck? Get it in one tap

Practice questions

Pick an answer, then read the explanation.

  1. Q1Easy

    Which research institution conducted the study on NR2F1 and NR2F6 in spinal cord injury?

  2. Q2Hard

    Consider the following statements about the NR2F1 and NR2F6 spinal cord injury study:

    • 1. The genes were delivered to mice after the spinal cord injury.
    • 2. Restoring either gene prompted damaged nerve fibres to regenerate across the injury site.
    • 3. Recovery in the treated mice was partial.

    Which of the statements given above are correct?

  3. Q3Medium

    By how much does the activity of NR2F1 and NR2F6 decline in adult brains, as found in the CCMB study?

  4. Q4Medium

    What is the potential application of the CCMB findings on NR2F1 and NR2F6?

Frequently asked questions

1. Which genes did CCMB identify for spinal nerve repair?

NR2F1 and NR2F6 promoted damaged nerve-fibre regrowth in mice with complete spinal cord injuries.

2. When did treated mice show recovery in the CCMB study?

Improvement became evident about five weeks after injury and continued thereafter.

3. Is the CCMB gene-based spinal cord treatment available for humans?

The research is at the preclinical stage. The mouse experiment produced partial recovery, with genes delivered before injury.

4. How did NR2F6 promote nerve regeneration in the CCMB study?

NR2F6 suppressed routine cellular activities and reorganised DNA, bringing growth-related genes closer to their regulatory elements.

All sources

Stories from the last 30 days on the same topic, state or exams

Science & TechUPSC: Important

Two rare MYH7 gene mutations linked to HCM identified by CCMB

  • Lead Institution: CSIR-Centre for Cellular and Molecular Biology (CCMB)
  • Sample size: 160 HCM patients + 178 healthy individuals (Telangana)
Background GK: Gene MutationNodal: CSIR-Centre for Cellular and Molecular BiologyDon't make this mistake!
4 questions · 2 minThe Hindu
Science & TechUPSC: Important

CSIR-CCMB maps TB bacterium's protein export, 92 key components identified

  • Research Body: CSIR-Centre for Cellular and Molecular Biology (CCMB)
  • Bacterium Studied: Mycobacterium tuberculosis (Mtb)
Background GK: Tuberculosis (TB)Nodal: CSIR-Centre for Cellular and Molecular Biology (CCMB)Don't make this mistake!
4 questions · 2 minThe Hindu